Market Cap
$656.0M
IRWD
IRONWOOD PHARMACEUTICALS INC
$3.64 ▼ -3.19%
Prev close $3.76Market cap$656.0M
12-mo target$6.10 (+67.6%)
Insider Selling Cluster (2 insiders)High Impact Filing (7/10)21 New Institutional Positions20 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on IRWD right now — valuation, ownership and activity at a glance.
Cap Size
Small Cap
Inst. Holders
50 funds
Inst. Value
$499.5M
Inst. Activity
21 buys / 20 sells
Insider Activity
$0.00 buy / $22.1M sell
Insider Net $
-$22.1M
SEC Reports
6
Price chart 30d -15.2%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 24, 2026 short_volume
Short Volume: IRWD — 64.8% short (0.4M / 0.6M)
Short: 385,586 | Exempt: 57,597 | TRF Vol: 594,922 | Short Ratio: 64.8% | Off-exchange volume (dark
Sep 15, 2026 Insider
Aug 6, 2026 SEC DENNER ALEXANDER J was granted 3,694 shares
Director
Ironwood Pharmaceuticals reported Q2 2026 GAAP EPS of $0.31, beating the $0.28 consensus by 10.7%, on revenue of $113.0M
8-K — Impact 7/10
Jul 20, 2026 Insider
Silber Jeffrey was granted 137,036 shares
SVP, CMO, Head-Res&Drug
Jul 7, 2026 Insider
Silver Ronald sold 127,890 shares
PFO & PAO @ $4.52 ($578.1K)
Jun 30, 2026 Inst.
BlackRock, Inc. — ADD
17,788,557 shares ($74.9M)
Jun 30, 2026 Inst.
May 13, 2026 SEC CHARLES SCHWAB INVESTMENT MANAGEMENT — TRIM
3,302,242 shares ($13.9M)
IRWD CFO Gregory Martini resigned effective May 15, 2026, with Ronald Silver serving as interim CFO. The resignation is
8-K — Impact 6/10
Analyst ratings buy % +7000.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Feb 26, 2026 | Citizens | MAINTAIN | Market Outperform | 38% |
| Jan 5, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | 54% |
| Jan 5, 2026 | Citizens | UPGRADE | Market Outperform | 38% |
| Nov 11, 2025 | Wells Fargo | MAINTAIN | Equal-Weight | 54% |
| Apr 15, 2025 | Wells Fargo | DOWNGRADE | Equal-Weight | 54% |
| Apr 15, 2025 | Jefferies | DOWNGRADE | Hold | 53% |
| Apr 14, 2025 | Leerink Partners | MAINTAIN | Market Perform | 49% |
| Jan 30, 2025 | JMP Securities | MAINTAIN | Market Outperform | 53% |
| Jan 22, 2025 | Craig-Hallum | MAINTAIN | Buy | 54% |
| Sep 9, 2024 | Leerink Partners | INITIATE | Market Perform | 49% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 5 | 3 | 0 | 0 | 70% | |
| Aug 1, 2026 | 2 | 5 | 3 | 0 | 0 | 70% | |
| Jul 1, 2026 | 2 | 5 | 3 | 0 | 0 | 70% | |
| Jun 1, 2026 | 2 | 5 | 3 | 0 | 0 | 70% | |
| May 1, 2026 | 2 | 5 | 3 | 0 | 0 | 70% | |
| Apr 1, 2026 | 2 | 5 | 3 | 0 | 0 | 70% | |
| Mar 1, 2026 | 2 | 5 | 3 | 0 | 0 | 70% | |
| Feb 1, 2026 | 2 | 5 | 3 | 0 | 0 | 70% |
Price targets
Where 4 covering analysts think IRWD trades over the next 12 months.
$6.10 +67.6% upside Strong Buy
Current$3.64 Low$3.70 Median$5.35 High$10.00 4 analysts
$3.70$10.00
Analyst rating None as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
6 SEC filing reports analyzed · 2 bullish, 3 bearish, 1 mixed, 0 neutral · avg impact 6.3/10.
BULLISH8-K7/10
Ironwood Pharmaceuticals reported Q2 2026 GAAP EPS of $0.31, beating the $0.28 consensus by 10.7%, o
Aug 6, 2026
MIXED8-K6/10
IRWD CFO Gregory Martini resigned effective May 15, 2026, with Ronald Silver serving as interim CFO.
May 13, 2026
BULLISH8-K7/10
Ironwood Pharmaceuticals reported a massive Q1 2026 beat with GAAP EPS of $0.24 vs $0.07 consensus (
May 7, 2026
BEARISHCLUSTER6/10
Six open-market share sales by three C-suite executives at Ironwood Pharmaceuticals (IRWD) over the
Feb 26, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 24, 2026
short_volume
Short Volume: IRWD — 64.8% short (0.4M / 0.6M)
Short: 385,586 | Exempt: 57,597 | TRF Vol: 594,922 | Short Ratio: 64.8% | Off-exchange volume (dark pool + OTC)
Sep 23, 2026
short_volume
Short Volume: IRWD — 56.0% short (0.3M / 0.6M)
Short: 329,952 | Exempt: 11 | TRF Vol: 589,275 | Short Ratio: 56.0% | Off-exchange volume (dark pool + OTC)
Sep 22, 2026
short_volume
Short Volume: IRWD — 59.7% short (0.3M / 0.6M)
Short: 345,552 | Exempt: 0 | TRF Vol: 578,940 | Short Ratio: 59.7% | Off-exchange volume (dark pool + OTC)
Sep 18, 2026
short_volume
Short Volume: IRWD — 71.3% short (0.4M / 0.6M)
Short: 438,759 | Exempt: 18 | TRF Vol: 615,017 | Short Ratio: 71.3% | Off-exchange volume (dark pool + OTC)
Sep 11, 2026
short_volume
Short Volume: IRWD — 61.9% short (0.4M / 0.6M)
Short: 353,437 | Exempt: 234 | TRF Vol: 570,705 | Short Ratio: 61.9% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.31 | $0.30–$0.32 | 29.2% | +0.0% | 1↑ 0↓ | $0.1B | 2 |
| Next Q | $0.34 | $0.34–$0.34 | 3500.0% | -13.6% | 1↑ 0↓ | $0.1B | 2 |
| Current FY | $1.21 | $1.20–$1.22 | 384.0% | +0.0% | 1↑ 0↓ | $0.5B | 2 |
| Next FY | $1.50 | $1.25–$1.82 | 24.0% | +0.0% | 0↑ 1↓ | $0.5B | 3 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.310 | — |
| 7d ago | $0.310 | — |
| 30d ago | $0.310 | — |
| 60d ago | $0.290 | +0.020 |
| 90d ago | $0.290 | +0.020 |
Institutional ownership
Which big funds own IRWD (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $499.5M total value (118,642,295 shares) as of 2026-Q2. Top holders: BlackRock,, STATE, BANK. Net buying activity: 21 institutions added/increased vs 20 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 17,788,557 | $74.9M | 15.0% | ADD +33.1% |
| STATE STREET CORP | 8,809,601 | $37.1M | 7.4% | ADD +69.0% |
| BANK OF AMERICA CORP /DE/ | 8,683,803 | $36.6M | 7.3% | — |
| RENAISSANCE TECHNOLOGIES LLC | 7,993,226 | $33.7M | 6.7% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,608,508 | $27.8M | 5.6% | — |
| AQR CAPITAL MANAGEMENT LLC | 6,465,921 | $27.2M | 5.4% | ADD +59.5% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5,513,355 | $23.2M | 4.6% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 4,831,657 | $20.3M | 4.1% | ADD +25.4% |
| TWO SIGMA INVESTMENTS, LP | 4,556,089 | $19.2M | 3.8% | — |
| MARSHALL WACE, LLP | 4,290,093 | $18.1M | 3.6% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | ADD | 13,362,930 | 17,788,557 | +33.1% | $74.9M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | TRIM | 4,737,857 | 3,302,242 | -30.3% | $13.9M |
| MACKENZIE FINANCIAL CORP | DOUBLED | 560,034 | 2,367,493 | +322.7% | $10.0M |
| MORGAN STANLEY | DOUBLED | 824,819 | 1,859,914 | +125.5% | $7.8M |
| WELLS FARGO & COMPANY/MN | DOUBLED | 58,850 | 1,206,198 | +1949.6% | $5.1M |
| STATE OF WISCONSIN INVESTMENT BOARD | ADD | 598,159 | 778,515 | +30.2% | $3.3M |
| CITADEL ADVISORS LLC | DOUBLED | 118,276 | 502,403 | +324.8% | $2.1M |
| VOYA INVESTMENT MANAGEMENT LLC | DOUBLED | 145,819 | 484,450 | +232.2% | $2.0M |
| SEI INVESTMENTS CO | TRIM | 742,548 | 459,417 | -38.1% | $1.9M |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | DOUBLED | 128,243 | 438,911 | +242.2% | $1.8M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
14 insiders, 28 transactions. Net -$22.1M — $0.00 bought, $22.1M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | DENNER ALEXANDER J | Director | AWARD | 3,694 | — | — |
| Jul 20, 2026 | Silber Jeffrey | SVP, CMO, Head-Res&Drug | AWARD | 137,036 | — | — |
| Jul 7, 2026 | Silver Ronald | PFO & PAO | SELL | 127,890 | $4.52 | $578.1K |
| Jun 16, 2026 | Duane Jon R | Director | AWARD | 63,481 | — | — |
| Jun 16, 2026 | Kessler Marla L | Director | AWARD | 63,481 | — | — |
| Jun 16, 2026 | Moukheibir Catherine | Director | AWARD | 63,481 | — | — |
| Jun 16, 2026 | Currie Mark G | Director | AWARD | 63,481 | — | — |
| Jun 16, 2026 | Shepard Jay | Director | AWARD | 63,481 | — | — |
| Jun 16, 2026 | McHugh Julie | Director | SELL | 21,571 | $3.73 | $80.5K |
| Jun 16, 2026 | McHugh Julie | Director | AWARD | 63,481 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for IRWD.
Shares short
18,728,986
Settlement Sep 15, 2026
Change vs prior
+6.1%
Semi-monthly cycle
Days to cover
13.1
At avg daily volume
Of shares outstanding
≈11.3%
Estimate — not % of float
All IRWD filing & press-release reports (6)
- 8-K reportAug 6, 2026
- 8-K reportMay 13, 2026
- 8-K reportMay 7, 2026
- CLUSTER reportFeb 26, 2026
- CLUSTER reportFeb 25, 2026
- 8-K reportFeb 25, 2026